Furthermore, repression of anti-ferroptosis genes (Gpx4, Nfe2l2 and Gclc, for instance) by a histone methyltransferase G9a in neurons was recently discovered as a mechanism that drives disease progression in the mouse model of MS and in humans afflicted by MS (59). Here, GCLC is linked to myeloid sarcoma.